Categories
Tags
-
#quality management clinical trials
#biomedical science news
#bispecific antibody platform
#single b cell antibody technologies
#science drug discovery
#protein nucleic acid complex
#biomedical innovation and development
#biomedical science news articles
#cell research
#quality control center
#center pharmaceutical
#news article about science and technology
#nucleic acid protein interaction
#drug discovery and drug design
Archives
Pilot R&D and Production Platform
-
Pilot R&D Pipeline and Production Platform
Having the ability of development of small scale processes and pilot production. The expression of Fed-Batch culture reaches the international leading level.
Having drug design and drug discovery platforms of affinity chromatography, ion exchange chromatography, composite mode chromatography, nano filtration and other purification chromatography technologies. Having capacity of fine purification of target antibodies and production of high purity protein stock solution.
Having a mature preparation filling platform, which produces different specifications of drug products such as pre-filled syringes, vials, and cilin bottles, and the filling accuracy exceeds the industry average level.
If you want to know more about research and development pipeline, please visit our website.
Sungen Biomedical was founded in 2019 which is an innovative antibody drug research and development biology enterprise incubated by Hotgen Biotech (SH688068), a listed company on the Shanghai Stock Exchange. The co-founder of Sungen Biomedical is Professor Zhiwei Sun, Vice Chairman of China Monoclonal Antibody Industry Committee.